However, studies of lipid antigen presentation in LSD patients are scarce; to date, the analysis of lipid antigen presentation in LSD patients is restricted to NPC disease where only CD1d-mediated presentation was studied using EBV transformed B cell lines as antigen presenting cells (APCs) (31). The gene discussed is CD1D; the disease is nasopharyngeal carcinoma.